Key result
Pulse rate ≥100 bpm is linked to an ~7-fold increase in early adverse events after PE.
Why the study?
Insight in the determinants of adverse clinical outcome is warranted to enable outpatient treatment of selected patients with pulmonary embolism.
Do pulse rate and D-dimer concentration predict short-term serious adverse events in patients with acute pulmonary embolism?
Cohort (n=440)
Do pulse rate and D-dimer concentration predict short-term serious adverse events in patients with acute pulmonary embolism?
Pulse rate ≥ 100 bpm and D-dimer ≥ 3,000 μg/ml can identify acute PE patients at high risk for short-term serious adverse events, suggesting these patients should not be treated in an outpatient setting.
Answers are grounded in this paper and cite their sources.
These thresholds may flag higher short-term risk in acute PE; hypothesis-generating and should not yet alter risk stratification.
To enable outpatient treatment of a selected group of patients with pulmonary embolism (PE), insight in the determinants of adverse clinical outcome is warranted. We have identified risk factors for serious adverse events (SAE) within the first 10 days of acute PE. We have retrospectively analysed data of 440 consecutive patients with acute PE. Collected data included age, gender, medical history, blood pressure, pulse rate and D-dimer concentration. The variables associated with SAE in the first 10 days in univariate analysis (p<0.15) have been included in a multivariate logistic regression model (backward conditional, p out >0.10). In 440 patients with acute PE, 20 SAEs occurred in a 10-day follow-up period. Pulse rate > or = 100 beats per minute (bpm) (OR, 6.85; 95%CI 1.43-32.81) and D-dimer concentration > or = 3,000 microg/ml (OR, 5.51; 95%CI 0.68-44.64) were significantly related to the SAEs. All SAEs were predicted by a pulse rate > or = 100 bpm and/or a D-dimer concentration > or = 3,000 microg/ml. Older age, gender, history of venous thromboembolism (VTE), heart failure, chronic obstructive pulmonary disease, cancer or a systolic blood pressure < 90 mm Hg had no significant influence on short term SAEs. Pulse rate and D-dimer concentration can be used to identify patients with acute PE, who are at risk for adverse clinical outcome during the first 10 days of hospitalisation. Outpatient treatment of PE-patients with a pulse rate > or = 100 bpm and/or a D-dimer concentration > or = 3,000 microg/ml has to be discouraged.
No takes yet. Share an insight, caveat, or question.
Bladel et al. (2009) conducted a cohort in acute pulmonary embolism (n=440). Pulse rate ≥ 100 bpm vs. Pulse rate < 100 bpm was evaluated on Serious adverse events (SAE) within the first 10 days (OR 6.85, 95% CI 1.43-32.81). A pulse rate ≥100 bpm and D-dimer ≥3,/ml were associated with serious adverse events within 10 days in patients with acute pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: